(Q50529699)
Statements
1 reference
Once- versus twice-daily amikacin regimen: efficacy and safety in systemic gram-negative infections. Scandinavian Amikacin Once Daily Study Group. (English)
1 reference
Maller R
1 reference
Ahrne H
1 reference
Holmen C
1 reference
Lausen I
1 reference
Nilsson LE
1 reference
Smedjegård J
1 reference
1 June 1993
1 reference
31
1 reference
939-948
1 reference
6
1 reference
Identifiers
1 reference
1 reference